These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 6265406

  • 1. Increased responsiveness to adenosine 3'5'-cyclic monophosphate-active agents during the immune response in vivo.
    Plaut M.
    Immunopharmacology; 1981 Jun; 3(2):107-16. PubMed ID: 6265406
    [Abstract] [Full Text] [Related]

  • 2. The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents.
    Plaut M, Marone G, Gillespie E.
    J Immunol; 1983 Dec; 131(6):2945-52. PubMed ID: 6315818
    [Abstract] [Full Text] [Related]

  • 3. The role of cyclic AMP in modulating cytotoxic T lymphocytes. I. In-vivo-generated cytotoxic lymphocytes, but not in vitro-generated cytotoxic lymphocytes, are inhibited by cyclic AMP-active agents.
    Plaut M.
    J Immunol; 1979 Aug; 123(2):692-701. PubMed ID: 222842
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP.
    Honeysett JM, Insel PA.
    J Cyclic Nucleotide Res; 1981 Aug; 7(5):321-32. PubMed ID: 6284819
    [Abstract] [Full Text] [Related]

  • 5. The elevation of mouse thymus cell cyclic adenosine monophosphate (cAMP) by lipopolysaccharide.
    Tsien WH, Sampson M, Sheppard H.
    Immunopharmacology; 1981 Sep; 3(3):253-8. PubMed ID: 6273361
    [Abstract] [Full Text] [Related]

  • 6. Role of cyclic AMP in differentiation of human neuroblastoma cells in culture.
    Prasad KN, Kumar S.
    Cancer; 1975 Oct; 36(4):1338-43. PubMed ID: 240503
    [Abstract] [Full Text] [Related]

  • 7. Prostaglandin E2 inhibits apoptosis in human neutrophilic polymorphonuclear leukocytes: role of intracellular cyclic AMP levels.
    Ottonello L, Gonella R, Dapino P, Sacchetti C, Dallegri F.
    Exp Hematol; 1998 Aug; 26(9):895-902. PubMed ID: 9694511
    [Abstract] [Full Text] [Related]

  • 8. Cyclic AMP as the second messenger for prostaglandin E in modulating suppressor cell-activation by natural suppressor/cytotoxic cells.
    Almawi WY, Murphy MG, Ogbaghebriel A, Pope BL.
    Int J Immunopharmacol; 1987 Aug; 9(6):697-704. PubMed ID: 2826350
    [Abstract] [Full Text] [Related]

  • 9. The effects of theophylline and 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO 20-1724) on protein secretion from rat parotid gland.
    Afari G, Tenenhouse A, Vachon C.
    Br J Pharmacol; 1982 Nov; 77(3):405-11. PubMed ID: 6291691
    [Abstract] [Full Text] [Related]

  • 10. Control of cyclic adenosine 3':5'-monophosphate-elevating effect of adenosine in C-1300 murine neuroblastoma in tissue culture.
    Green RD.
    J Pharmacol Exp Ther; 1977 Dec; 203(3):610-20. PubMed ID: 200733
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of bradykinin stimulation of renal medullary prostaglandin E2 synthesis by phosphodiesterase inhibitors.
    Rapp NS, Zenser TV, Mattammal MB, Davis BB.
    J Pharmacol Exp Ther; 1981 Nov; 219(2):442-6. PubMed ID: 6169824
    [Abstract] [Full Text] [Related]

  • 12. On the role of cyclic AMP in the cytotoxic effect of fluoride.
    Holland RI, Hongslo JK, Christoffersen T.
    Acta Pharmacol Toxicol (Copenh); 1980 Jan; 46(1):66-72. PubMed ID: 6244715
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandin E2, adenosine 3':5'-cyclic monophosphate and changes in endometrial vascular permeability in rat uteri sensitized for the decidual cell reaction.
    Kennedy TG.
    Biol Reprod; 1983 Dec; 29(5):1069-76. PubMed ID: 6317067
    [Abstract] [Full Text] [Related]

  • 14. Two mechanisms of inhibition by prostaglandin E2 of hormone-dependent cell cAMP in the rat collecting tubule.
    Chabardès D, Montégut M, Zhou Y, Siaume-Perez S.
    Mol Cell Endocrinol; 1990 Oct 22; 73(2-3):111-21. PubMed ID: 1702742
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
    Lerner U, Ransjö M, Fredholm BB.
    Biochem Pharmacol; 1986 Dec 01; 35(23):4177-89. PubMed ID: 2431692
    [Abstract] [Full Text] [Related]

  • 16. Effect of adenosine 3',5'-cyclic monophosphate (cAMP) on human non-tumorigenic and tumorigenic parotid acinar cells in culture.
    Krause G, Kumar R, Meyers A, Prasad KN.
    Cancer Lett; 1996 Nov 12; 108(1):73-9. PubMed ID: 8950212
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of 3',5'-nucleotide phosphodiesterase and the stimulation of cerebral cyclic AMP formation by biogenic amines in vitro and in vivo.
    Nahorski SR, Rogers KJ.
    Neuropharmacology; 1976 Oct 12; 15(10):609-12. PubMed ID: 186725
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.